Skip to main content
. Author manuscript; available in PMC: 2013 Mar 16.
Published in final edited form as: Mol Pharm. 2011 Mar 23;8(3):709–715. doi: 10.1021/mp100272k

Figure 7.

Figure 7

G3139 accumulation and Bcl-2 expression in tumors

Panel A. Tumor accumulation profile of FAM-G3139. Following tail i.v. bolus administration of 5 mg/kg of FAM-G3139 loaded sLPD, LPD, or free FAM-G3139 in tumor-bearing mouse (n=3). Each point represents Mean ± SD of three mice.

Panel B. Immunohistochemical staining of Bcl-2 in tumors. Frozen sections were prepared from tumors after 4 times of 5 mg/kg treatment with free G3139 or sLPD-G3139 and stained with anti-human Bcl-2 antibodies.